Industries > Pharma > Latin American Pharmaceutical Market Outlook 2015-2025

Latin American Pharmaceutical Market Outlook 2015-2025

PUBLISHED: 21 September 2015
PAGES: 140
SUBMARKET: Regional Markets

WOOCS 2.2.1
SKU: PHA0066 Categories: ,

What can be expected from the Latin American pharmaceutical market? Which areas are going to grow at the fastest rates? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Our 140-page report provides 121 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. You will see financial results, interviews, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.

Latin American Pharmaceutical Market Outlook 2015-2025

See revenue forecasts for the leading international markets
How will leading national markets perform to 2025? Our study forecasts revenues in national markets including by product class for the following countries:
• Brazil
• Mexico
• Venezuela
• Argentina
• Colombia
• Chile

Leading companies and potential for market growth
Overall revenue for the Latin American pharmaceutical market will reach $87.29bn in 2018, our work forecasts. We predict strong revenue growth through to 2025. The ageing population in many of the region’s largest markets will combine with increasing investment in national health care systems to drive sales to 2025.

Our work analyses the key companies in the market. See Visiongain’s analysis of 5 leading companies, including these:
• Sanofi
• Novartis
• Pfizer
• Bayer

A company profile gives you the following information where available:
• Historical revenues from 2013 to 2014
• Discussion of a company’s activities and outlook
• Brief assessment of the companies Latin American strategy

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

Latin American Pharmaceutical Market Outlook 2015-2025

What issues will affect the Latin American pharmaceutical industry?
Our new report discusses issues and events affecting the Latin American pharmaceutical market. You will find discussions, including qualitative analyses:
• Highly diverse region needing strong knowledge of each national market
• Quickly evolving regulatory environment
• Economic weaknesses encouraging innovation

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Latin American Pharmaceutical Market Outlook 2015-2025 report helps you
In summary, our 140-page report gives you the following knowledge:
• Revenue forecasts to 2025 for the Latin American pharmaceutical market – discover the industry’s prospects, finding promising places for investments and revenues
• Revenue forecasts to 2025 for the leading regional markets – Brazil, Mexico, Venezuela, Argentina, Colombia, Chile
• Economic situation across the nations of Latin America – Understand the pressures faced across the region and how to achieve growth in an increasingly challenging environment
• Assessment of 5 leading companies – analysis of Latin American results and strategies
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the Latin American Pharmaceutical market and leading companies. You find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Latin American Pharmaceutical Market Outlook 2015-2025

Download sample pages

Complete the form below to download your free sample pages for Latin American Pharmaceutical Market Outlook 2015-2025

Latest Pharma news

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021


Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021


Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021


Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021